This website is intended for healthcare professionals

Weight loss drugs

Patients to wait 12 years to access weight loss drug Mounjaro

The National Institute for Health and Care Excellence is prioritising the drug for people with highest needs to ‘protect the NHS’ from being overwhelmed

Weight-loss jabs could get unemployed people ‘back to work,’ says Health and Social Care Secretary

Wes Streeting warned of the burden caused by ‘widening waistbands,’ and called for effective obesity treatments to ease ‘demands on our NHS’

First weight-loss jab approved to prevent heart attacks in the UK

Wegovy could reduce the risk of adverse cardiovascular events by 20%, marking an ‘important step forward’ in tackling the consequences of obesity

Weight-loss jabs could increase risk of condition causing blindness

Harvard University professors say that weight-loss injections could lead to blindness, but suggest findings are still ‘tentative’

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP